Form D — Nasus Pharma Ltd
0001493152-26-008057 · filed 2026-02-25
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $15,000,040
- Total sold
- $15,000,040
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Nasus Pharma Ltd
- CIK
- 2029039
- Entity
- Corporation
- Jurisdiction
- ISRAEL
- Year incorporated
- —
- Address
- 34 YITZHAK SADEH ST
TEL AVIV, L3 6274711 - Phone
- +972.3.573.6632
Related persons
-
Dan Teleman · Executive OfficerTEL AVIV, L3
-
Eyal Rubin · Executive OfficerTEL AVIV, L3
-
Udi Gilboa · DirectorTEL AVIV, L3
-
Dalia Megiddo · Executive OfficerTEL AVIV, L3
-
Ronnie Hershman · DirectorTEL AVIV, L3
-
David Silberman · DirectorTEL AVIV, L3
-
Sharon Shacham · DirectorTEL AVIV, L3
-
Isaac Israel · DirectorTEL AVIV, L3
View original on SEC EDGAR.